Product Information
ATOVAQUONE 750 MG/5 ML SUSP is a generic product labeled by PAI Holdings LLC, priced at $0.7030 per ML under NDC 00121095608. Its NADAC has been published 52 times since Jul 2, 2025.
Strength
750 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121095608
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA214272On Market Since
4/4/2025
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP has been published 52 times since Jul 2, 2025, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7030 per ML |
|---|---|
| All-time high | $0.8766 (Oct 15, 2025) |
| All-time low | $0.6910 (May 20, 2026) |
| 52-week high | $0.8766 |
| 52-week low | $0.6910 |
| Median price | $0.7455 |
| Average price | $0.7762 |
| Largest weekly change | -7.4% (Nov 19, 2025) |
| Weeks tracked | 52 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP, manufactured by PAI Holdings LLC, is $0.7030 per ML (NDC 00121095608), effective Jun 24, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has declined 17.8%. It has been tracked across 52 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP?
Since Jul 2, 2025, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has ranged from a low of $0.6910 (May 20, 2026) to a high of $0.8766 (Oct 15, 2025), with a median of $0.7455 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP?
9 NADAC-published products share the same active ingredient, strength, and dosage form as ATOVAQUONE 750 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP?
ATOVAQUONE 750 MG/5 ML SUSP (NDC 00121095608) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification